Are you a media representative looking for content on Bayer? This section provides access to media releases as well as feeds from our social media channels.


Your Selection
Clear All
Health Canada approves additional indication for NUBEQA® (darolutamide) for the treatment of metastatic castration-sensitive prostate cancer (mCSPC) in combination with docetaxel
In recognition of Breast Cancer Awareness Month, Bayer in Canada launches new breast cancer screening website for patients
On World Contraception Day, Bayer reaffirms commitment
Canadian post-secondary students in agriculture and food secure $96K
Canada's Farmers Grow Communities
Bayer makes $165,000 available to support rural-based charities
Bayer Inc. leadership team accepts the award for most admired cultues
Bayer Canada Named one of Canada’s Most Admired™ Corporate Cultures
Bayer Crop Science Launches 2022 Opportunity Scholarship Program for Students
Bayer extends clinical development program for finerenone with Phase II study investigating the initial combination therapy with empagliflozin in patients with chronic kidney disease and type 2 diabetes